Código 293719 (Harmonized System 2012 by 6 digits)
2023: US$27.9M, Total Trade Exchange
2023: US$517, International Sales
2023: US$27.9M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) was US$27.9M.
In 2020, the states with the most international sales in Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) were Ciudad de México (US$56.1k).
The states with the most international purchases in 2023 were Jalisco (US$25.8M), Ciudad de México (US$1.23M), and Estado de México (US$192k).
In 2020, the main commercial destinations of Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) were South Korea (US$53.7k), Guatemala (US$2.08k), Italy (US$300), and India (US$10).
The main commercial origins of Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) in 2023 were India (US$19.4M), Argentina (US$5.46M), Spain (US$1.3M), South Korea (US$456k), and China (US$341k).
In the global context, the main exporting countries of Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) in 2022 were Ireland (US$6.79B), Switzerland (US$2.71B), and United States (US$945M). In the same year, the main importing countries of Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) were United States (US$5.47B), Austria (US$2.77B), and Germany (US$1.31B).
US$27.9M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) in Mexico (including international purchases and sales) was US$27.9M.
The visualizations show the net balance of Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
November, 2024: US$710k, International Purchases
In November 2024, international sales of Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) were US$0, while international purchases reached US$710k. The above results in a trade balance of -US$710k.
Ciudad de México: US$56.1k, State with the Most International Sales (2020)
South Korea: US$53.7k, Main commercial destination (2020)
In 2020, the states with the highest international sales in Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) were Ciudad de México (US$56.1k).
In 2020, the countries with the most international purchases from Mexico were South Korea (US$53.7k), Guatemala (US$2.08k), Italy (US$300), and India (US$10).
Jalisco: US$25.8M, State with the Most International Purchases (2023)
India: US$19.4M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) were Jalisco (US$25.8M), Ciudad de México (US$1.23M), and Estado de México (US$192k).
The countries with the most international sales to Mexico in 2023 were India (US$19.4M), Argentina (US$5.46M), Spain (US$1.3M), South Korea (US$456k), and China (US$341k).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts). In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) were Ireland (US$6.79B), Switzerland (US$2.71B), and United States (US$945M). In the same year, the main importing countries for Polypeptide Hormones, Hormones and Hormones Proteinmeal Glycoprotein, their Derivatives and Structural Analogues Thereof, Used Primarily as Hormones (Exc. Somatotropin, its Derivatives and Structural Analogues, and Insulin and its Salts) were United States (US$5.47B), Austria (US$2.77B), and Germany (US$1.31B).